dehydroepiandrosterone sulfate has been researched along with fulvestrant in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calhoun, KE; Fletcher, WS; Muller, P; Pommier, RF; Toth-Fejel, S | 1 |
| Hardin, C; Jackson, T; Lefleur, B; Pommier, R; Toth-Fejel, S | 1 |
| Browne, AE; Chatterjee, K; Chou, TM; Hutchison, SJ; Ko, E; Komesaroff, PA; Sudhir, K; Zellner, C | 1 |
| Coombes, RC; Januszewski, A; Palmieri, C; Stanway, S | 1 |
1 review(s) available for dehydroepiandrosterone sulfate and fulvestrant
| Article | Year |
|---|---|
Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase II as Topic; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Fulvestrant; Humans; Neoplasms, Hormone-Dependent; Steryl-Sulfatase; Sulfonic Acids; Tamoxifen | 2011 |
3 other study(ies) available for dehydroepiandrosterone sulfate and fulvestrant
| Article | Year |
|---|---|
Dehydroepiandrosterone sulfate causes proliferation of estrogen receptor-positive breast cancer cells despite treatment with fulvestrant.
Topics: Breast Neoplasms; Cell Division; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; In Vitro Techniques; Receptors, Estrogen; Tumor Cells, Cultured | 2003 |
Understanding the biologic mechanisms responsible for breast-cancer progression during tamoxifen or fulvestrant treatment.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Disease Progression; Estradiol; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Tamoxifen; Treatment Failure; Tumor Cells, Cultured | 2004 |
Dehydroepiandrosterone sulfate induces acute vasodilation of porcine coronary arteries in vitro and in vivo.
Topics: Androgen Antagonists; Animals; ATP-Binding Cassette Transporters; Coronary Circulation; Coronary Vessels; Dehydroepiandrosterone Sulfate; Echocardiography, Doppler; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Female; Flutamide; Fulvestrant; Glyburide; Hemodynamics; In Vitro Techniques; KATP Channels; Male; NG-Nitroarginine Methyl Ester; Pericardium; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Sex Characteristics; Swine; Testosterone; Vasodilation | 2005 |